89R5865 MPF-D
 
  By: Cook S.B. No. 2257
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the definition and provision of an abortion-inducing
  drug.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 171.061(2), Health and Safety Code, is
  amended to read as follows:
               (2)  "Abortion-inducing drug" means a drug, a medicine,
  or any other substance, including a regimen of two or more drugs,
  medicines, or substances, prescribed, dispensed, or administered
  with the intent of terminating a clinically diagnosable pregnancy
  of a woman and with knowledge that the termination will, with
  reasonable likelihood, cause the death of the woman's unborn
  child.  The term includes off-label use of drugs, medicines, or
  other substances known to have abortion-inducing properties that
  are prescribed, dispensed, or administered with the intent of
  causing an abortion, including the Mifeprex regimen, and
  misoprostol (Cytotec)[, and methotrexate].  The term does not
  include a drug, medicine, or other substance that may be known to
  cause an abortion but is prescribed, dispensed, or administered for
  other medical reasons.
         SECTION 2.  Section 171.063(c), Health and Safety Code, is
  amended to read as follows:
         (c)  Before the physician provides an abortion-inducing
  drug, the physician must:
               (1)  examine the pregnant woman in person;
               (2)  independently verify that a pregnancy exists;
               (3)  [document, in the woman's medical record, the
  gestational age and intrauterine location of the pregnancy to
  determine whether an ectopic pregnancy exists;
               [(4)]  determine the pregnant woman's blood type, and
  for a woman who is Rh negative, offer to administer Rh
  immunoglobulin (RhoGAM) at the time the abortion-inducing drug is
  administered or used or the abortion is performed or induced to
  prevent Rh incompatibility, complications, or miscarriage in
  future pregnancies;
               (4) [(5)]  document whether the pregnant woman
  received treatment for Rh negativity, as diagnosed by the most
  accurate standard of medical care; and
               (5) [(6)]  ensure the physician does not provide an
  abortion-inducing drug for a pregnant woman whose pregnancy is more
  than 49 days of gestational age.
         SECTION 3.  (a) The changes in law made by this Act apply
  only to an offense committed on or after the effective date of this
  Act. An offense committed before the effective date of this Act is
  governed by the law in effect on the date the offense was committed,
  and the former law is continued in effect for that purpose. For
  purposes of this section, an offense was committed before the
  effective date of this Act if any element of the offense occurred
  before that date.
         (b)  The changes in law made by this Act apply only to the
  imposition of an administrative penalty for a violation that occurs
  on or after the effective date of this Act. The imposition of an
  administrative penalty for a violation that occurs before the
  effective date of this Act is governed by the law in effect on the
  date the violation occurred, and the former law is continued in
  effect for that purpose.
         SECTION 4.  This Act takes effect September 1, 2025.